ArticleHepatology (Baltimore, Md.)2020

Efficacy and Safety of 3-Year Denosumab Therapy for Osteoporosis in Patients With Autoimmune Liver Diseases.

Yoshitaka Arase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.